Long Term Outcomes of Open Versus Endovascular AAA Repair
开放性 AAA 修复与血管内修复 AAA 的长期结果
基本信息
- 批准号:8536355
- 负责人:
- 金额:$ 60.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-12-15 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:Abdominal Aortic AneurysmAgeBlood VesselsCause of DeathCessation of lifeClinical TrialsCollaborationsDataDevicesElderlyElderly manEmployee StrikesGeneral PopulationGrantHeadHealth Services ResearchHerniaHome Nursing CareInterventionIntervention StudiesIntestinal ObstructionLaparotomyLiving CostsLongitudinal StudiesMeasuresMedicareMorbidity - disease rateOperative Surgical ProceduresOutcomePatientsPerioperativePopulationPositioning AttributeQuality of lifeRandomized Controlled TrialsRehabilitation NursingReportingResearchRuptureRuptured Abdominal Aortic AneurysmSamplingScoring MethodStatistical MethodsTechniquesTechnologyTimeUnited StatesUnited States Centers for Medicare and Medicaid ServicesWorkbasecohortcomparative effectivenessfollow-uphead-to-head comparisonmembermenmortalityolder patientpreventprogramsrandomized trialrepaired
项目摘要
Project Summary: Ruptured abdominal aortic aneurysm (AAA) is the 10th leading cause of death in men over
age 55 in the US with mortality of ruptured AAA exceeding 80%. Up until recently, to prevent ruptures, elective
Open AAA repair was typically performed with mortality of d5%. Within the last decade, endovascular AAA
repair was introduced as a less invasive alternative to open repair. FDA approval for stentgraft repair of AAA
in the United States was granted in 1999 and the use of endovascular repair has steadily grown since that
time, replacing open surgery for many patients. Over 40,000 AAA repairs are performed annually in the United
States and by 2005, 56% of all elective AAA repairs performed in the Medicare population were endovascular.
Endovascular AAA repair has been shown to have a lower operative mortality and morbidity than open
repair in short-term head to head comparisons. However, recent randomized trials have not demonstrated a
sustained mortality benefit with endovascular repair. Endovascular repair also requires costly follow-up
surveillance and there is a greater need for re-interventions, although endovascular technologies continue to
evolve. In order to understand the comparative effectiveness of various interventions, it is important to extend
inquiry beyond small randomized controlled trials of ideal populations to study interventions in real world
settings using observational data. In the case of AAA repair, access to comprehensive data from the Medicare
program represents an ideal setting in which to perform comparative effectiveness studies as the vast majority
of AAA repairs (70%) are performed in this elderly population. Medicare data are also ideally suited to studies
that include longer term follow-up and the occurrence of uncommon complications.
The specific aims of this proposal are: 1) To study the long term outcomes of endovascular versus open
AAA repair in a comprehensive sample of Medicare patients undergoing elective repair; 2) To determine
whether changes in technology, as measured by the introduction of new endovascular products over time, has
impacted both perioperative and long term survival of those undergoing endovascular repair; and 3) To
rigorously define, quantify, and measure the impact of laparotomy related complications in the case of open
AAA repair and graft-related complications in the case of endovascular repair.
项目摘要:腹主动脉瘤破裂(AAA)是导致男性死亡的第十大原因。
美国55岁,腹主动脉破裂病死率超过80%。直到最近,为了防止破裂,可选的
开放性腹主动脉瘤修补术的死亡率为5%。在过去的十年里,血管内AAA
修复术是作为一种比开放修复术侵入性更小的选择而引入的。FDA批准AAA支架修复
美国于1999年批准了血管内修复,自那以来,血管内修复的使用一直在稳步增长
时间,取代了许多患者的开放手术。在美国,每年进行超过40,000次AAA维修
到2005年,在医疗保险人群中进行的所有选择性AAA修复中,56%是血管内修复。
血管内AAA修复术与开放手术相比,手术死亡率和发病率较低。
在短期的正面比较中修复。然而,最近的随机试验并没有证明
持续死亡率得益于血管内修复。血管内修复还需要昂贵的后续治疗
监测和再次干预的需要更大,尽管血管内技术继续
进化。为了了解各种干预措施的相对有效性,重要的是扩大
超越理想人群的小型随机对照试验研究现实世界中的干预措施
使用观测数据的设置。在AAA修复的情况下,访问来自Medicare的全面数据
该计划代表了进行比较有效性研究的理想环境,因为大多数
有70%的AAA修复术是在这一老年人群中进行的。医疗保险数据也非常适合于研究
这包括较长期的随访和罕见并发症的发生。
这项建议的具体目的是:1)研究血管内手术与开放手术的长期结果
在接受选择性修复的医疗保险患者中进行AAA修复的综合样本;2)确定
随着时间的推移,通过引入新的血管内产品来衡量技术的变化,是否
对接受血管内修复者的围手术期和长期生存的影响;以及3)
严格定义、量化和衡量开腹手术相关并发症的影响
血管内修复中的腹主动脉修复和移植物相关并发症。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Improving observational study estimates of treatment effects using joint modeling of selection effects and outcomes: the case of AAA repair.
使用选择效应和结果的联合建模改进治疗效果的观察性研究估计:AAA 修复案例。
- DOI:10.1097/mlr.0b013e3182363d64
- 发表时间:2011
- 期刊:
- 影响因子:3
- 作者:O'Malley,AJames;Cotterill,Philip;Schermerhorn,MarcL;Landon,BruceE
- 通讯作者:Landon,BruceE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce E. Landon其他文献
Dimensions of consumer-assessed quality of Medicare managed-care health plans.
消费者评估的医疗保险管理式医疗健康计划的质量维度。
- DOI:
10.1097/00005650-200002000-00006 - 发表时间:
2000 - 期刊:
- 影响因子:3
- 作者:
A. Zaslavsky;Nancy Dean Beaulieu;Bruce E. Landon;Paul D. Cleary - 通讯作者:
Paul D. Cleary
Emergency Department Visits And Hospital Capacity In The US: Trends In The Medicare Population During The COVID-19 Pandemic.
美国急诊科就诊和医院容量:COVID-19 大流行期间医疗保险人口的趋势。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:9.7
- 作者:
P. Smulowitz;A. O’Malley;J. McWilliams;Lawrence A Zaborski;Bruce E. Landon - 通讯作者:
Bruce E. Landon
Physician specialization and antiretroviral therapy for HIV
- DOI:
10.1046/j.1525-1497.2003.20705.x - 发表时间:
2003-04-01 - 期刊:
- 影响因子:4.200
- 作者:
Bruce E. Landon;Ira B. Wilson;Susan E. Cohn;Carl J. Fichtenbaum;Mitchell D. Wong;Neil S. Wenger;Samuel A. Bozzette;Martin F. Shapiro;Paul D. Cleary - 通讯作者:
Paul D. Cleary
Approaches to Comparing the Impact of Socioeconomic Disadvantage on Acute Myocardial Infarction Care Within and Across Countries: A Scoping Review
比较社会经济劣势对各国内部及不同国家间急性心肌梗死治疗影响的方法:一项范围综述
- DOI:
10.1016/j.cjca.2024.03.013 - 发表时间:
2024-06-01 - 期刊:
- 影响因子:5.300
- 作者:
Leo E. Akioyamen;Dennis T. Ko;Peter Cram;Bruce E. Landon - 通讯作者:
Bruce E. Landon
MP5-19 THE IMPACT OF CARE COORDINATION ON RADICAL PROSTATECTOMY OUTCOMES
- DOI:
10.1016/j.juro.2015.02.246 - 发表时间:
2015-04-01 - 期刊:
- 影响因子:
- 作者:
John M. Hollingsworth;Russell J. Funk;Spencer A. Garrison;Jason Owen-Smith;Samuel R. Kaufman;Bruce E. Landon;James E. Montie;Brahmajee K. Nallamothu - 通讯作者:
Brahmajee K. Nallamothu
Bruce E. Landon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce E. Landon', 18)}}的其他基金
Risk Aversion, Fear of Malpractice, and Medical Decision Making in the Emergency Department
风险规避、对医疗事故的恐惧与急诊科的医疗决策
- 批准号:
10474364 - 财政年份:2019
- 资助金额:
$ 60.16万 - 项目类别:
Comparing Targeted and Non-Targeted Approaches to Improving the Value of Cancer Care Services
比较提高癌症护理服务价值的靶向和非靶向方法
- 批准号:
9895590 - 财政年份:2019
- 资助金额:
$ 60.16万 - 项目类别:
Risk Aversion, Fear of Malpractice, and Medical Decision Making in the Emergency Department
风险规避、对医疗事故的恐惧与急诊科的医疗决策
- 批准号:
10242666 - 财政年份:2019
- 资助金额:
$ 60.16万 - 项目类别:
Comparing Targeted and Non-Targeted Approaches to Improving the Value of Cancer Care Services
比较提高癌症护理服务价值的靶向和非靶向方法
- 批准号:
10374837 - 财政年份:2019
- 资助金额:
$ 60.16万 - 项目类别:
PA-20-070 Identifying Predictors of Hospital Admission from the ED Among the Elderly
PA-20-070 确定老年人急诊室入院的预测因素
- 批准号:
10175813 - 财政年份:2017
- 资助金额:
$ 60.16万 - 项目类别:
Identifying Predictors of Hospital Admission from the ED Among the Elderly
从急诊科确定老年人入院的预测因素
- 批准号:
9365351 - 财政年份:2017
- 资助金额:
$ 60.16万 - 项目类别:
Identifying Predictors of Hospital Admission from the ED Among the Elderly
从急诊科确定老年人入院的预测因素
- 批准号:
10015296 - 财政年份:2017
- 资助金额:
$ 60.16万 - 项目类别:
Long Term Outcomes of Open Versus Endovascular AAA Repair
开放性 AAA 修复与血管内修复 AAA 的长期结果
- 批准号:
8205001 - 财政年份:2010
- 资助金额:
$ 60.16万 - 项目类别:
Long Term Outcomes of Open Versus Endovascular AAA Repair
开放性 AAA 修复与血管内修复 AAA 的长期结果
- 批准号:
8020566 - 财政年份:2010
- 资助金额:
$ 60.16万 - 项目类别:
Improving Medicare in an Era of Change: Deaths in Long-Term Care Facilities During the COVID-19 Era
在变革时代改善医疗保险:COVID-19 时代长期护理机构的死亡人数
- 批准号:
10288393 - 财政年份:2009
- 资助金额:
$ 60.16万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 60.16万 - 项目类别:
Research Grant